The Department of Pharmaceuticals (DoP) has rejected a review application of Abbott Healthcare filed against National Pharmaceutical Pricing Authority (NPPA) on fixation of ceiling price for modified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback